Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
31,632
-29,727
-48% -$464K 0.04% 594
2026
Q1
$772K Sell
61,359
-13,161
-18% -$133K 0.08% 416
2025
Q4
$648K Buy
74,520
+60,431
+429% +$524K 0.08% 346
2025
Q3
$132K Buy
+14,089
New +$131K 0.02% 531
2025
Q2
Sell
-154,144
Closed -$1.34M 443
2025
Q1
$1.34M Sell
154,144
-76,629
-33% -$771K 0.25% 119
2024
Q4
$1.92M Buy
230,773
+21,859
+10% +$161K 0.53% 49
2024
Q3
$1.24M Sell
208,914
-1,934
-0.9% -$10.8K 0.33% 98
2024
Q2
$1.11M Buy
210,848
+122,334
+138% +$623K 0.4% 73
2024
Q1
$482K Buy
+88,514
New +$564K 0.21% 140

Other funds holding ADTN

Numerai's ADTN Position: Q2 2026 in Review

Numerai reduced its Adtran (ADTN) stake by 48% in Q2 2026, selling an estimated $464K and leaving 31,632 shares worth $440K. The position accounts for 0.04% of the portfolio, ranked #594.

Numerai first reported a position in ADTN in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.92M in Q4 2024. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Numerai held 31,632 shares of Adtran worth $440K as of Q2 2026.
  • Numerai sold 29,727 Adtran shares in Q2 2026, an estimated $464K.
  • Adtran made up 0.04% of Numerai's portfolio in Q2 2026, its #594 holding.
  • Numerai first reported a position in Adtran in Q1 2024 and has held it in 9 quarters since.
  • Numerai's Adtran position peaked at $1.92M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Numerai's 13F filing for Q2 2026, filed 14 Aug 2026.